Inthera Bioscience intherabio.com

Inthera Bioscience, founded in 2013, employs a proprietary technology platform to rationally design protein-protein interaction inhibitors. The company has discovered disruptors of hypoxia-inducible signaling for the treatment of solid tumors and targeted agents against HPV- associated cancer, which are in pre-clinical development. Inthera Bioscience is a biopharmaceutical company focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology pl...Show all

Inthera Bioscience, founded in 2013, employs a proprietary technology platform to rationally design protein-protein interaction inhibitors. The company has discovered disruptors of hypoxia-inducible signaling for the treatment of solid tumors and tar...Show all

Company (Alive / Active)

All investors data 5 Investors

• Aglaia Oncology Funds
• Erfindungs Verwertung
• Merck Ventures
• Novo Holdings
• Novo Seeds

There is no Investors data available for this company. Please select another tab.

There is no Board of Directors data available for this company. Please select another tab.

Board Members

There is no Competitors data available for this company. Please select another tab.

Competitors

See all 0 competitors

Patents